SEPN

AS OF

Nov 13, 04:59 PM (EDT)

Price

$19.23

Change

-$0.00 (-0.00%)

Capitalization

862.13M

Intraday BUY SELL Signals

OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

SEPN

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Septerna (SEPN) Ownership - Who owns Septerna?

Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Details

Group

Domestic Stock Funds

Fundamentals

SEPN

Capitalization

862M

P/E Ratio

N/A

Risk (Beta)

N/A

Dividend Yield

N/A

Total Cash

327M

Total Cash/Share

7.29

Total Debt

24.6M

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

0.49%

Revenue

726K

ROE

N/A

Book Value

378M

P/B Ratio

2.22

Cash Flow

N/A

Earnings

-7.58

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

45K

Current Ratio

22.09

Current Revenue Per Employee

1586.67

Dividends Per Share - Security

N/A

EBITDA

-100.6M

Float

N/A

Float - Current

N/A

Gross Income Margin

N/A

Revenue To Assets

-29.57

Shares Held By Institutions

550M

Shares Outstanding - Current

44.8M

Total Liabilities

37.7M

Total Volume MTD

N/A

Value

Gain YTD

-16.026

View a ticker or compare two or three

Compare

SEPN

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.

View AI-Driven Trading for SEPN

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details